Status:

UNKNOWN

Bicarbonate vs Heparin Catheter Lock in Chronic Hemodialysis Patients

Lead Sponsor:

Hospital General "Dr. Miguel Silva" de Morelia

Collaborating Sponsors:

Universidad Nacional Autonoma de Mexico

NAUSLIFE HEMODIALYSIS CLINICS

Conditions:

End Stage Renal Disease

Vascular Access Complication

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

Prospective clinical trial to evaluate the efficacy of catheter lock with bicarbonate vs heparin in chronic hemodialysis patients. Two groups will be created, sodium bicarbonate lock group (experiment...

Detailed Description

A prospective, randomized, clinical, open-label trial at Hospital General "Dr. Miguel Silva" de Morelia, Mexico. The study period will be between august 16, 2019 to November 16, 2019. The aim of this...

Eligibility Criteria

Inclusion

  • Patients who accept participation and sign informed consent.
  • Incident or prevalent chronic hemodialysis patients who receive at least 2 sessions per week with 1 month of clinical stability defined as: no hospitalizations, no vascular access infections, no changes in blood flow prescription due to vascular access dysfunction.
  • Patients with temporal catheter (Niagra 13.5 French/20 cm length, BARD Access System, Salt Lake City, Utah, USA) as vascular access for hemodialysis.

Exclusion

  • Catheter dysfunction at baseline
  • On anticoagulation therapy
  • Patients with known coagulopathy or hemophilia
  • Patients with Child-Pugh B or C liver failure
  • Patients with thrombocytopenia less than 100,000 u / L
  • Patients with central vessel stenosis and vena cava syndrome, previously documented.
  • Patients with vascular access exhaustion.
  • Patients who have undergone more than 2 vascular approaches for hemodialysis catheters.
  • Patients with heparin-induced thrombocytopenia

Key Trial Info

Start Date :

September 11 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 28 2020

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04054128

Start Date

September 11 2019

End Date

September 28 2020

Last Update

April 30 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital General "Dr. Miguel Silva" de Morelia

Morelia, Michoacán, Mexico, 58020